MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 72 filers reported holding MILLENDO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 9.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $324,000 | -7.4% | 199,000 | 0.0% | 0.05% | -13.1% |
Q2 2020 | $350,000 | -89.2% | 199,000 | -67.5% | 0.06% | -92.9% |
Q1 2020 | $3,231,000 | -21.7% | 611,900 | 0.0% | 0.86% | +6.3% |
Q4 2019 | $4,124,000 | +359.8% | 611,900 | +688.2% | 0.81% | +368.6% |
Q2 2019 | $897,000 | +199.0% | 77,629 | +288.1% | 0.17% | +191.5% |
Q1 2019 | $300,000 | +88.7% | 20,000 | 0.0% | 0.06% | +68.6% |
Q4 2018 | $159,000 | – | 20,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,396,615 | $16,145,000 | 4.14% |
GREAT POINT PARTNERS LLC | 1,288,093 | $14,891,000,000 | 1.65% |
NEA Management Company, LLC | 1,766,779 | $20,424,000 | 1.43% |
Bpifrance SA | 1,078,670 | $12,469,000 | 1.34% |
ADAMS STREET PARTNERS LLC | 409,146 | $4,730,000 | 0.88% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,825 | $2,056,000 | 0.76% |
Prosight Management, LP | 73,868 | $854,000 | 0.43% |
Samsara BioCapital, LLC | 45,101 | $521,000 | 0.34% |
AWM Investment Company, Inc. | 77,629 | $897,000 | 0.17% |
GMT CAPITAL CORP | 53,419 | $618,000 | 0.02% |